WANBURY.BO
Wanbury LimitedExplain this page
Arphra AIPlain-English read on Wanbury Limited’s valuationCompany profile
DB · companies + sec_company_profile + company_profilesWanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Identifiers
- SymbolWANBURY.BO
- Legal nameWanbury Limited
- CEOPradeep Patni
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CountryIN
- CurrencyINR
- ExchangeBSE
- IPO dateFeb 07, 2005
- CIK
- ISININE107F01022
- CUSIP—
- LEI—
- Employees1,491
Trading
DB · key_metrics_ttm- Market cap$8.97B
- P/E (TTM)—
- P/B—
- EV / EBITDA—
- Dividend yield—